Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Sunbelt Wellness Institute is Northeast Florida’s first center to provide innovative solutions to those struggling with Post Traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) when previous trials on antidepressants have failed to provide relief. Together, they are one of the primary causes of disability in the United States affecting, by some estimates, upwards of 16 million individuals. Of those, approximately, 1/3 fail to respond to traditional antidepressant medication regimens. Among those that do, the positive effects of those treatments take weeks to months to manifest.

Ketamine Infusion therapy in collaboration with mental health professionals and anesthesia clinicians offer a tremendous opportunity for healing and progress in these individuals. Although ketamine has traditionally been used as an anesthetic, it has also been used off label to treat chronic pain, and now Treatment Resistant Depression (TRD). Ketamine has shown the ability to improve the response to traditional antidepressants and improves the rapidity of response that professionals are not seeing with the pure antidepressant effect alone.

Ketamine infusion treatments alone aren’t a solution, but they offer the potential to turn the the tide and hope for improved responses when in collaboration with mental health colleagues.

For more information, contact us at info@sunbeltwellness.com

National Institute of Mental Health (NIMH). Major depression. Updated November 2017. https://www.nimh.nih.gov/health/statistics/major-depression.shtml. Accessed January 25, 2018

World Health Organization (WHO). Depression fact sheet. Updated February 2017. http://www.who.int/mediacentre/factsheets/fs369/en/. Accessed January 25, 2018

Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: recent developments and clinical applications (http://ebmh.bmj.com/content/19/2/35) . Evid Based Ment Health. 2016;19(2):35-38.

Wan LB, Levitch CF, Perez AM, et al. Ketamine safety and tolerability in clinical trials for treatment-resistant depression (http://www.psychiatrist.com/jcp/article/Pages/2015/v76n03/v76n0302.aspx) . J Clin Psychiatry. 2015;76(3):247-252.

Excerpts referenced from an article posted by Batya Swift Yasgur, MA, LSW retrieved from http://www.psychiatryadvisor.com/depression-advisor/ketamine-promising-treatment-resistant-depression-treatment/article/744492/

Leave a Comment

Your email address will not be published. Required fields are marked *

More To Explore

Ketamine Clinic

Learn about Sun Belt Wellness’ Ketamine Infusion Therapy

We’ve come a long way as a society in de-stigmatizing mental illness–depression, PTSD, anxiety, etc. Still, those with mental health issues often struggle to find sufficient treatment. Enter Ketamine Infusion Therapy. Long since approved by the FDA for its use as anesthesia, Ketamine has been found more recently to help with pain management and mood

Ketamine Clinic

Sunbelt Wellness Institute Now Offers Spravato (esketamine)

Spravato (esketamine) was approved this year (2019) by the FDA in the treatment of refractory depression.  Sunbelt Wellness Institute is proud to offer this treatment that may improve the affordability of care through insurance coverage.  While we understand that evidence surrounding its efficacy is underwhelming, there has been a growing portion of anecdotal reports directly